팔로우
Ying Xu
Ying Xu
Postdoc at University of Pennsylvania
pharm.ecnu.edu.cn의 이메일 확인됨
제목
인용
인용
연도
Biomimetic metal–organic framework nanoparticles for cooperative combination of antiangiogenesis and photodynamic therapy for enhanced efficacy
H Min, J Wang, Y Qi, Y Zhang, X Han, Y Xu, J Xu, Y Li, L Chen, K Cheng, ...
Advanced Materials 31 (15), 1808200, 2019
3502019
Reversal of pancreatic desmoplasia by re-educating stellate cells with a tumour microenvironment-activated nanosystem
X Han, Y Li, Y Xu, X Zhao, Y Zhang, X Yang, Y Wang, R Zhao, ...
Nature communications 9 (1), 3390, 2018
3182018
Sulforaphane mediates glutathione depletion via polymeric nanoparticles to restore cisplatin chemosensitivity
Y Xu, X Han, Y Li, H Min, X Zhao, Y Zhang, Y Qi, J Shi, S Qi, Y Bao, G Nie
ACS nano 13 (11), 13445-13455, 2019
1312019
Modularly designed peptide nanoprodrug augments antitumor immunity of PD-L1 checkpoint blockade by targeting indoleamine 2, 3-dioxygenase
X Han, K Cheng, Y Xu, Y Wang, H Min, Y Zhang, X Zhao, R Zhao, ...
Journal of the American Chemical Society 142 (5), 2490-2496, 2020
1152020
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
X Han, MG Alameh, K Butowska, JJ Knox, K Lundgreen, M Ghattas, ...
Nature Nanotechnology 18 (9), 1105-1114, 2023
952023
An extendable star-like nanoplatform for functional and anatomical imaging-guided photothermal oncotherapy
X Han, Y Xu, Y Li, X Zhao, Y Zhang, H Min, Y Qi, GJ Anderson, L You, ...
ACS nano 13 (4), 4379-4391, 2019
772019
Investigating crosstalk between H3K27 acetylation and H3K4 trimethylation in CRISPR/dCas-based epigenome editing and gene activation
W Zhao, Y Xu, Y Wang, D Gao, J King, Y Xu, FS Liang
Scientific reports 11 (1), 15912, 2021
652021
Emerging nanomedicines for anti-stromal therapy against desmoplastic tumors
X Han, Y Xu, M Geranpayehvaghei, GJ Anderson, Y Li, G Nie
Biomaterials 232, 119745, 2020
652020
Inducible and reversible RNA N6-methyladenosine editing
H Shi, Y Xu, N Tian, M Yang, FS Liang
Nature communications 13 (1), 1958, 2022
602022
Synthesis and imaging of biocompatible graphdiyne quantum dots
H Min, Y Qi, Y Chen, Y Zhang, X Han, Y Xu, Y Liu, J Hu, H Liu, Y Li, G Nie
ACS applied materials & interfaces 11 (36), 32798-32807, 2019
542019
In situ combinatorial synthesis of degradable branched lipidoids for systemic delivery of mRNA therapeutics and gene editors
X Han, J Xu, Y Xu, MG Alameh, L Xue, N Gong, R El-Mayta, R Palanki, ...
Nature Communications 15 (1), 1762, 2024
172024
Fast and facile synthesis of amidine-incorporated degradable lipids for versatile mRNA delivery in vivo
X Han, MG Alameh, N Gong, L Xue, M Ghattas, G Bojja, J Xu, G Zhao, ...
Nature chemistry 16 (10), 1687-1697, 2024
112024
A split CRISPR/Cas13b system for conditional RNA regulation and editing
Y Xu, N Tian, H Shi, C Zhou, Y Wang, FS Liang
Journal of the American Chemical Society 145 (9), 5561-5569, 2023
112023
Site‐Specific m6A Erasing via Conditionally Stabilized CRISPR‐Cas13b Editor
Y Xu, Y Wang, FS Liang
Angewandte Chemie 135 (43), e202309291, 2023
42023
On demand CRISPR-mediated RNA N6-methyladenosine editing
Y Xu, FS Liang
Genes & Diseases 9 (6), 1389, 2022
22022
Optimization of the activity and biodegradability of ionizable lipids for mRNA delivery via directed chemical evolution
X Han, MG Alameh, Y Xu, R Palanki, R El-Mayta, G Dwivedi, KL Swingle, ...
Nature Biomedical Engineering 8 (11), 1412-1424, 2024
2024
A CRISPR-based Strategy for Temporally Controlled Site-Specific Editing of RNA Modifications
Y Xu, Y Wang, FS Liang
Bio-protocol 13 (3), 2023
2023
The Emerging Gene Regulatory Landscape Through RNA Modifications, Encyclopedia of Cell Biology, Second Edition (CLB2)
YX Fu-Sen Liang
2023
Studies of Developing CRISPR-Based Chemically Inducible Tools for Site-specific Editing of RNA Modification
Y Xu
Case Western Reserve University, 2023
2023
현재 시스템이 작동되지 않습니다. 나중에 다시 시도해 주세요.
학술자료 1–19